Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Epidemiology|June 17, 2025
Estimating and presenting non-linear associations with restricted cubic splinesAndrea Discacciati, Michael G Palazzolo, Jeong-Gun Park, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancerC Gridelli, S De Placido, R Pepe, et al.
International Journal of Sports Medicine|November 28, 2014
Cardiovascular responses during free-diving in the seaE Marongiu, A Crisafulli, G Ghiani, et al.
International Journal of Sports Medicine|September 30, 2014
Muscle ischemic preconditioning does not improve performance during self-paced exerciseF Tocco, E Marongiu, G Ghiani, et al.
European Journal of Immunology|March 1, 1996
Natural killer clones recognize specific soluble HLA class I moleculesE Carbone, G Terrazzano, M Colonna, et al.
Current Medicinal Chemistry|June 6, 2012
The role of EGFR tyrosine kinase inhibitors in the first-line treatment of advanced non small cell lung cancer patients harboring EGFR mutationA Sgambato, F Casaluce, P Maione, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 26, 2022
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trialSiddharth M Patel, Michael G Palazzolo, Sabina A Murphy, et al.
International Journal of Cardiology|May 21, 2023
Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trialAntonio Fagundes, Christian T Ruff, David A Morrow, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
JAMA Cardiology|July 10, 2024
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialAndré Zimerman, Eugene Braunwald, Jan Steffel, et al.
Pageof 4